Senna (sennosides) / Remedica - LARVOL DELTA

Marksans Pharma arm receives regulatory approval for Sennosides tablets, shares gain 6% (CNBC-TV18) - "Shares of Marksans Pharma gained over 6% on Monday, May 19, as the company said its wholly-owned subsidiary Relonchem Limited in the United Kingdom received market authorisation for Sennosides 7.5 mg tablets from the UK Medicines and Healthcare Products Regulatory Agency. The Sennosides tablets are used to treat constipation as per the US government's MedlinePlus website."

Commercial • MHRA approval • Gastrointestinal Disorder

Improving Outcomes in Advanced RCC: Translating Evidence to Clinical Practice - Episode 30: Patient Profile Presentation: A 56-Year-Old Man with Clear Cell RCC (OncLive) - "Robert Alter, MD: I'm going to go to the third case, and we'll get a little more detailed about it. Maybe we'll use a different regimen that we haven't seen before. I had a 56-year-old gentleman. In his medical history you see hypertension, hyperlipidemia, and gastritis. Past surgeries included cholecystectomy, right knee replacement, and cataracts. Medications at home [were Percocet, Norvasc, Lipitor, and senna]...."

Video